Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells
In the central nervous system, fibroblast growth factor (FGF)-20 has been reported to act preferentially on midbrain dopaminergic neurons. It also promotes the dopaminergic differentiation of stem cells. We have analyzed the effects of FGF-20 on human embryonic stem cells (hESCs) differentiation int...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2007-12-01
|
Series: | Frontiers in Neuroanatomy |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/neuro.05.004.2007/full |
id |
doaj-2dd4048c93974bfd84d16ee3e9cb9f2b |
---|---|
record_format |
Article |
spelling |
doaj-2dd4048c93974bfd84d16ee3e9cb9f2b2020-11-25T00:18:54ZengFrontiers Media S.A.Frontiers in Neuroanatomy1662-51292007-12-01110.3389/neuro.05.004.2007162Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cellsAna Sofia Correia0Sergey V Anisimov1Laurent Roybon2Jia-Yi Li3Patrik Brundin4Neuronal Survival Unit, Department of Experimental Medical Science, Lund University, Wallenberg Neuroscience CenterNeuronal Survival Unit, Department of Experimental Medical Science, Lund University, Wallenberg Neuroscience CenterNeuronal Survival Unit, Department of Experimental Medical Science, Lund University, Wallenberg Neuroscience CenterNeuronal Survival Unit, Department of Experimental Medical Science, Lund University, Wallenberg Neuroscience CenterNeuronal Survival Unit, Department of Experimental Medical Science, Lund University, Wallenberg Neuroscience CenterIn the central nervous system, fibroblast growth factor (FGF)-20 has been reported to act preferentially on midbrain dopaminergic neurons. It also promotes the dopaminergic differentiation of stem cells. We have analyzed the effects of FGF-20 on human embryonic stem cells (hESCs) differentiation into dopaminergic neurons. We induced neuronal differentiation of hESCs by co-culturing those with PA6 mouse stromal cells for 3 weeks. When we supplemented the culture medium with FGF-20, the number of tyrosine hydroxylase (TH)- expressing neurons increased fivefold, from 3% to 15% of the hESC-derived cells. The cultured cells also expressed other midbrain dopaminergic markers (PITX3, En1, Msx1, and Aldh1), suggesting that some had differentiated into midbrain dopaminergic neurons. We observed no effect of FGF-20 on the size of the soma area or neurite length of the TH-immunopositive neurons. Regardless of whether FGF-20 had been added or not, 17% of the hESC-derived cells expressed the pan-neuronal marker b-III-Tubulin. The proportion of proliferating cells positive for Ki-67 was also not affected by FGF-20 (7% of the hESC-derived cells). By contrast, after 3 weeks in culture FGF-20 significantly reduced the proportion of cells undergoing cell death, as revealed by immunoreactivity for cleaved caspase-8, Bcl-2 associated X protein (BAX) and cleaved caspase-3 (2.5% to 1.2% of cleaved caspase-3-positive cells out of the hESC-derived cells). Taken together, our results indicate that FGF-20 specifically increases the yield of dopaminergic neurons from hESCs grown on PA6 feeder cells and at least part of this effect is due to a reduction in cell death.http://journal.frontiersin.org/Journal/10.3389/neuro.05.004.2007/fullApoptosisDopaminergic NeuronsParkinson's diseasedifferentiationStem Cell Therapycaspase-3 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ana Sofia Correia Sergey V Anisimov Laurent Roybon Jia-Yi Li Patrik Brundin |
spellingShingle |
Ana Sofia Correia Sergey V Anisimov Laurent Roybon Jia-Yi Li Patrik Brundin Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells Frontiers in Neuroanatomy Apoptosis Dopaminergic Neurons Parkinson's disease differentiation Stem Cell Therapy caspase-3 |
author_facet |
Ana Sofia Correia Sergey V Anisimov Laurent Roybon Jia-Yi Li Patrik Brundin |
author_sort |
Ana Sofia Correia |
title |
Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells |
title_short |
Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells |
title_full |
Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells |
title_fullStr |
Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells |
title_full_unstemmed |
Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells |
title_sort |
fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Neuroanatomy |
issn |
1662-5129 |
publishDate |
2007-12-01 |
description |
In the central nervous system, fibroblast growth factor (FGF)-20 has been reported to act preferentially on midbrain dopaminergic neurons. It also promotes the dopaminergic differentiation of stem cells. We have analyzed the effects of FGF-20 on human embryonic stem cells (hESCs) differentiation into dopaminergic neurons. We induced neuronal differentiation of hESCs by co-culturing those with PA6 mouse stromal cells for 3 weeks. When we supplemented the culture medium with FGF-20, the number of tyrosine hydroxylase (TH)- expressing neurons increased fivefold, from 3% to 15% of the hESC-derived cells. The cultured cells also expressed other midbrain dopaminergic markers (PITX3, En1, Msx1, and Aldh1), suggesting that some had differentiated into midbrain dopaminergic neurons. We observed no effect of FGF-20 on the size of the soma area or neurite length of the TH-immunopositive neurons. Regardless of whether FGF-20 had been added or not, 17% of the hESC-derived cells expressed the pan-neuronal marker b-III-Tubulin. The proportion of proliferating cells positive for Ki-67 was also not affected by FGF-20 (7% of the hESC-derived cells). By contrast, after 3 weeks in culture FGF-20 significantly reduced the proportion of cells undergoing cell death, as revealed by immunoreactivity for cleaved caspase-8, Bcl-2 associated X protein (BAX) and cleaved caspase-3 (2.5% to 1.2% of cleaved caspase-3-positive cells out of the hESC-derived cells). Taken together, our results indicate that FGF-20 specifically increases the yield of dopaminergic neurons from hESCs grown on PA6 feeder cells and at least part of this effect is due to a reduction in cell death. |
topic |
Apoptosis Dopaminergic Neurons Parkinson's disease differentiation Stem Cell Therapy caspase-3 |
url |
http://journal.frontiersin.org/Journal/10.3389/neuro.05.004.2007/full |
work_keys_str_mv |
AT anasofiacorreia fibroblastgrowthfactor20increasestheyieldofmidbraindopaminergicneuronsderivedfromhumanembryonicstemcells AT sergeyvanisimov fibroblastgrowthfactor20increasestheyieldofmidbraindopaminergicneuronsderivedfromhumanembryonicstemcells AT laurentroybon fibroblastgrowthfactor20increasestheyieldofmidbraindopaminergicneuronsderivedfromhumanembryonicstemcells AT jiayili fibroblastgrowthfactor20increasestheyieldofmidbraindopaminergicneuronsderivedfromhumanembryonicstemcells AT patrikbrundin fibroblastgrowthfactor20increasestheyieldofmidbraindopaminergicneuronsderivedfromhumanembryonicstemcells |
_version_ |
1725374393745408000 |